These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 3938260
21. [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia]. Palmieri M, Capucci A, Lombardi G, Naccarella F, Bomba E, Bracchetti D. G Ital Cardiol; 1984 May; 14(5):357-9. PubMed ID: 6468817 [Abstract] [Full Text] [Related]
22. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]. Ventosa A, Adragão P, Bonhorst D, Seabra-Gomes R. Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653 [Abstract] [Full Text] [Related]
23. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring]. Tsuchiya M, Kasanuki H, Ohnishi S, Hosoda S. J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400 [Abstract] [Full Text] [Related]
24. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M. Indian Heart J; 1996 Nov; 48(2):133-7. PubMed ID: 8682552 [Abstract] [Full Text] [Related]
29. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment]. Garimoldi M, Sghirinzetti M, Pirastu A, Cappiello E, Sala R, Terranova P. G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383 [Abstract] [Full Text] [Related]
30. [Therapy of ventricular tachyarrhythmias refractory to lidocaine with propafenone (author's transl)]. Laimer H, Glogar D, Zilcher H. Acta Med Austriaca; 1981 Apr; 8(5):140-4. PubMed ID: 7331741 [Abstract] [Full Text] [Related]
31. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia. Manz M, Steinbeck G, Lüderitz B. Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693 [Abstract] [Full Text] [Related]
32. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up. Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H. Int J Cardiol; 2006 Mar 08; 107(3):360-8. PubMed ID: 16503259 [Abstract] [Full Text] [Related]
38. [Serial testing of antiarrhythmic agents using programmed stimulation in recurrent ventricular tachycardia]. Lukl J, Cíhalík C, Heinc P. Vnitr Lek; 1992 Mar 08; 38(3):246-51. PubMed ID: 1595215 [Abstract] [Full Text] [Related]
39. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide. Karagueuzian HS, Sugi K, Ohta M, Meesmann M, Ino T, Peter T, Mandel WJ. Am Heart J; 1986 Dec 08; 112(6):1173-83. PubMed ID: 3788764 [Abstract] [Full Text] [Related]
40. [Reduction of ventricular tachycardia by programmed electric stimulation. Clinical implications]. Lacombe P, Metge M, Cointe R, Bru P, Lévy S. Arch Mal Coeur Vaiss; 1987 Aug 08; 80(9):1365-8. PubMed ID: 3122686 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]